Publications by authors named "Ana Yuste"

Claim this Profile
D
Diagnostic yield of follow-up in patients undergoing surgery for non-metastatic colorectal cancer.
Noelia Sala-Miquel, José Carrasco-Muñoz, Soledad Bernabeu-Mira, Carolina Mangas-Sanjuan, Sandra Baile-Maxía, Ana Yuste

World J Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional, comparative, syndromic description of oncological mixed pain in Medical Oncology units in Spain.
Santiago Ponce, Ana Yuste, Ana Esquivias, Ana Leal, Jesús Villoria

Support Care Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.
Oscar Murcia, Míriam Juárez, María Rodríguez-Soler, Eva Hernández-Illán, Mar Giner-Calabuig, Ana Yuste

PLoS One· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete pathological response after chemotherapy alone in a patient with pancreatic adenocarcinoma.
Silvia Carbonell, Javier Espinosa, Antonio Zarco, Enrique de-Madaria, Javier de la Hoz, Ana Yuste

Pancreas· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late diagnosis of an index case of SDH-related paraganglioma/pheochromocytoma syndrome.
Myriam Sánchez-Pacheco Tardón, Sol Serrano Corredor, Ana Carrión, Montserrat Mauri, Ana Yuste

Endocrinol Nutr· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma.
Fernando Rivera, Maica Galán, Josep Tabernero, Andres Cervantes, Maria Eugenia Vega-Villegas, Ana Lucia Yuste

Cancer Chemother Pharmacol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticotropin-releasing hormone-secreting pancreatoblastoma in an adult patient.
Evangelina Boix, Ana Yuste, Andrés Meana, Eduardo Alcaraz, Artemio Payá

Pancreas· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma.
Fernando Rivera, Maica Galán, Josep Tabernero, Andres Cervantes, M Eugenia Vega-Villegas, Ana Lucia Yuste

Int J Radiat Oncol Biol Phys· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study.
Albert Abad, Bartomeu Massuti, Antonio Antón, Maria Eugenia Vega, Ana L Yuste

Acta Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Amyopathic dermatomyositis associated with a recurrence of breast cancer].
Mar Blanes, José Bañuls, Ana Yuste, Encarna Adrover, José C Pascual

Actas Dermosifiliogr· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of the combination of oxaliplatin, irinotecan and continuous infusion 5-fluorouracil in digestive tumors.
Albert Abad, Bartomeu Massutí, Javier Gallego, Ana L Yuste, José Luis Manzano

Anticancer Drugs· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary lymphoma of bone: a clinico-pathological review and analysis of prognostic factors.
Ana L Yuste, Angel Segura, Pedro López-Tendero, Regina Gironés, Joaquín Montalar

Leuk Lymphoma· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of clinical prognostic factors for survival and time to progression in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapy.
Ana L Yuste, Jorge Aparicio, Angel Segura, Pedro López-Tendero, Regina Gironés

Clin Colorectal Cancer· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxic epidermal necrolysis associated with interleukin-2.
Angel A Segura Huerta, Pablo Tordera, Ana C Cercós, Ana L Yuste, Pedro López-Tendero

Ann Pharmacother· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase I study of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancer.
Jorge Aparicio, Ramón de las Peñas, José María Vicent, Salvador Garcerá, Cristina Llorca, Ana L Yuste

Oncology· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primitive neuroectodermal kidney tumor.
Angel Segura, Jose Pérez, Gaspar Reynés, Ana Yuste, Francisco Vera

Med Pediatr Oncol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis